Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016 (2016), Article ID 4161679, 5 pages
http://dx.doi.org/10.1155/2016/4161679
Case Report

Pure White Cell Aplasia and Necrotizing Myositis

1Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
2Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
3Department of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, USA

Received 26 January 2016; Accepted 2 March 2016

Academic Editor: Akimichi Ohsaka

Copyright © 2016 Peter Geon Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Cline, G. Opelz, A. Saxon, J. L. Fahey, and D. W. Golde, “Autoimmune panleukopenia,” The New England Journal of Medicine, vol. 295, no. 27, pp. 1489–1493, 1976. View at Publisher · View at Google Scholar · View at Scopus
  2. L. J. Levitt, C. A. Ries, and P. L. Greenberg, “Pure white-cell aplasia. Antibody-mediated autoimmune inhibition of granulopoiesis,” The New England Journal of Medicine, vol. 308, no. 19, pp. 1141–1146, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Iida, T. Noda, S. Banno, M. Nitta, K. Takada, and M. Yamamoto, “Pure white cell aplasia (PWCA) with an inhibitor against colony-forming unit of granulocyte-macrophage (CFU-GM),” Rinsho Ketsueki, vol. 31, no. 10, pp. 1726–1730, 1990. View at Google Scholar · View at Scopus
  4. S. P. Ackland, M. E. Bur, S. S. Adler, M. Robertson, and J. M. Baron, “White blood cell aplasia associated with thymoma,” American Journal of Clinical Pathology, vol. 89, no. 2, pp. 260–263, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Yip, J. E. J. Rasko, C. Lee, H. Kronenberg, and B. O'Neill, “Thymoma and agranulocytosis: two case reports and literature review,” British Journal of Haematology, vol. 95, no. 1, pp. 52–56, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Fumeaux, P. Beris, B. Borisch et al., “Complete remission of pure white cell aplasia associated with thymoma, autoimmune thyroiditis and type 1 diabetes,” European Journal of Haematology, vol. 70, no. 3, pp. 186–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Tamura, M. Okamoto, T. Yamashita et al., “Pure white cell aplasia: report of the first case associated with primary biliary cirrhosis,” International Journal of Hematology, vol. 85, no. 2, pp. 97–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. W. Mamus, J. D. Burton, J. D. Groat, D. A. Schulte, M. Lobell, and E. D. Zanjani, “Ibuprofen-associated pure white-cell aplasia,” The New England Journal of Medicine, vol. 314, no. 10, pp. 624–625, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Levitt, “Chlorpropamide-induced pure white cell aplasia,” Blood, vol. 69, no. 2, pp. 394–400, 1987. View at Google Scholar · View at Scopus
  10. B. Anger, S. Reichert, and H. Heimpel, “Clozapine-induced agranulocytosis,” Blut, vol. 54, no. 1, pp. 63–64, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Kalambokis, A. Vassou, K. Bourantas, and E. V. Tsianos, “Imipenem-cilastatin induced pure white cell aplasia,” Scandinavian Journal of Infectious Diseases, vol. 37, no. 8, pp. 619–620, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Pont, E. Puchhammer-Stockl, A. Chott et al., “Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection,” British Journal of Haematology, vol. 80, no. 2, pp. 160–165, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Herzog-Tzarfati, E. Shiloah, M. Koren-Michowitz, S. Minha, and M. J. Rapoport, “Successful treatment of prolonged agranulocytosis caused by acute parvovirus B19 infection with intravenous immunoglobulins,” European Journal of Internal Medicine, vol. 17, no. 6, pp. 439–440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Barbui, R. Bassan, P. Viero, B. Minetti, B. Comotti, and M. Buelli, “Pure white cell aplasia treated by high dose intravenous immunoglobulin,” British Journal of Haematology, vol. 58, no. 3, pp. 554–555, 1984. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. E. Betteridge, H. Gunawardena, and N. J. McHugh, “Novel autoantibodies and clinical phenotypes in adult and juvenile myositis,” Arthritis Research and Therapy, vol. 13, no. 2, article 209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Mohassel and A. L. Mammen, “Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies,” Muscle and Nerve, vol. 48, no. 4, pp. 477–483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Rigolet, L. Musset, O. Dubourg et al., “Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease,” Medicine, vol. 91, no. 2, pp. 95–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. E. C. Decroos, L. D. Hobson-Webb, V. C. Juel, J. M. Massey, and D. B. Sanders, “Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?” Muscle & Nerve, vol. 49, no. 1, pp. 30–34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Romi, G. O. Skeie, N. E. Gilhus, and J. A. Aarli, “Striational antibodies in myasthenia gravis: reactivity and possible clinical significance,” Archives of Neurology, vol. 62, no. 3, pp. 442–446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. T. Stravitz, H. Chung, R. K. Sterling et al., “Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C,” American Journal of Gastroenterology, vol. 100, no. 6, pp. 1415–1419, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. Levitt, G. R. Reyes, D. K. Moonka, K. Bensch, R. A. Miller, and E. G. Engleman, “Human T cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease,” The Journal of Clinical Investigation, vol. 81, no. 2, pp. 538–548, 1988. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Ide, M. Sata, R. Nouno, F. Yamashita, H. Nakano, and K. Tanikawa, “Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia,” American Journal of Gastroenterology, vol. 89, no. 2, pp. 257–262, 1994. View at Google Scholar · View at Scopus
  23. K. Zhu, J. Chen, and S. Chen, “Treatment of Epstein-Barr virus—associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review,” Hematology, vol. 10, no. 5, pp. 365–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Fisch, R. Handgretinger, and H.-E. Schaefer, “Pure red cell aplasia,” British Journal of Haematology, vol. 111, no. 4, pp. 1010–1022, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Strandell, A. Bate, S. Hägg, and I. R. Edwards, “Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction,” British Journal of Clinical Pharmacology, vol. 68, no. 3, pp. 427–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Reuben, D. G. Koch, and W. M. Lee, “Drug-induced acute liver failure: results of a U.S. multicenter, prospective study,” Hepatology, vol. 52, no. 6, pp. 2065–2076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kajiguchi and T. Ohno, “Azithromycin-related agranulocytosis in an elderly man with acute otitis media,” Internal Medicine, vol. 48, no. 12, pp. 1089–1091, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Nguyen, R. Brar, and S. L. Schrier, “The varying clinical picture of pure-white cell aplasia,” Journal of Blood Disorders & Transfusion, vol. 5, article 218, 2014. View at Publisher · View at Google Scholar
  29. G. Chakupurakal, R. J. A. Murrin, and J. R. Neilson, “Prolonged remission of pure white cell aplasia (PWCA), in a patient with CLL, induced by rituximab and maintained by continuous oral cyclosporin,” European Journal of Haematology, vol. 79, no. 3, pp. 271–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Hellmich, E. Csernok, H. Schatz, W. L. Gross, and A. Schnabel, “Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 46, no. 9, pp. 2384–2391, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. D. Schwartz, “Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody,” Pharmacotherapy, vol. 22, no. 6, pp. 783–788, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Schwab and F. Nimmerjahn, “Intravenous immunoglobulin therapy: how does IgG modulate the immune system?” Nature Reviews Immunology, vol. 13, no. 3, pp. 176–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. G. J. Xu, T. Kula, Q. Xu et al., “Comprehensive serological profiling of human populations using a synthetic human virome,” Science, vol. 348, no. 6239, Article ID aaa0698, 2015. View at Publisher · View at Google Scholar · View at Scopus